Tyra Biosciences, Inc. TYRA Increase Decrease In Right Of Use Assets And Lease Liabilities Net
Increase Decrease In Right Of Use Assets And Lease Liabilities Net at other companies
Other financials
Where this comes from
Reported directly by Tyra Biosciences, Inc. in its filing.
Tagged under the XBRL concept tyra:IncreaseDecreaseInRightOfUseAssetsAndLeaseLiabilitiesNet.
The official record: Tyra Biosciences, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tyra Biosciences, Inc.'s increase decrease in right of use assets and lease liabilities net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tyra Biosciences, Inc.'s increase decrease in right of use assets and lease liabilities net?
- Tyra Biosciences, Inc. (TYRA) reported increase decrease in right of use assets and lease liabilities net of $17K in Q1 2026.
- How has Tyra Biosciences, Inc.'s increase decrease in right of use assets and lease liabilities net changed year-over-year?
- Tyra Biosciences, Inc.'s increase decrease in right of use assets and lease liabilities net decreased by 22.7% year-over-year, from $22K to $17K.
- What is the long-term trend for Tyra Biosciences, Inc.'s increase decrease in right of use assets and lease liabilities net?
- Over 3 years (2021 to 2025), Tyra Biosciences, Inc.'s increase decrease in right of use assets and lease liabilities net has grown at a -15.0% compound annual growth rate (CAGR), from $135K to $83K.
- What does increase decrease in right of use assets and lease liabilities net mean?
- This metric captures the net impact of operating lease liabilities and corresponding right-of-use assets on cash flow. It reflects non-cash adjustments related to lease accounting standards that reconcile the difference between lease expense and actual cash payments made for leases.